Full Text View
Tabular View
No Study Results Posted
Related Studies
Psychopharmacology of Psilocybin in Cancer Patients
This study is currently recruiting participants.
Verified July 2012 by Sidney Kimmel Comprehensive Cancer Center
Study NCT00465595   Information provided by Sidney Kimmel Comprehensive Cancer Center

First Received on April 23, 2007.   Last Updated on July 9, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Depressive Symptoms
Anxiety
Cancer
Additional conditions recognized in this trial
Anxiety Disorders
Depression
More general conditions related to this trial
Behavioral Symptoms
Mental Disorders
Interventions listed in this trial
psilocybin
Additional drug interventions recognized in this trial
N,N-Dimethyltryptamine
Psilocybine
More general drug interventions related to this trial
Central Nervous System Agents
Hallucinogens
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Serotonin Agents
Serotonin Antagonists
Serotonin Receptor Agonists
Therapeutic Uses
Sponsors listed in this trial
Sidney Kimmel Comprehensive Cancer Center
Heffter Research Institute


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services